Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South
University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive
medicine at the University of South China
· Professional training at Huazhong University
of Science and Technology and Tongji
Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Which country is more suitable for test tube with thin endometrium, thin endometrial test tube, overseas test tube country selection, hysteroscopy evaluation, frozen embryo transfer scheme, repeated implantation failure, endometrial preparation process, cross-border assisted reproduction.
Which country is more suitable for making test tubes with thin endometrium? Don't rush to choose a country yet, these six judgment points are more critical.
Thin endometrium, what are you talking about?
In the context of assisted reproduction, "endometrial thinness" is usually not a simple image description, but a clinical problem that will affect embryo implantation strategy. In the existing research and guideline discussion, the pre-transplant intima thickness ≤7mm is often regarded as the focus of attention in clinic, but the definitions of different studies are not completely consistent, which is why some patients can still get pregnant despite their "thin intima", while some people have unsatisfactory outcomes even if they reach the value. In other words, intimal thickness is not the only index, but intimal morphology, blood flow, etiology, uterine environment and embryo quality are equally important.
From the first principle, the core task of endometrium is not to "thicken" itself, but to form an acceptable window for embryo implantation. If intrauterine adhesion, previous curettage injury, chronic inflammation and poor endometrial response after repeated transplant failure are behind the thin intima, then simply changing a country to do test tubes will not automatically solve the problem. What really needs to be asked is not "which country to go to", but whether the team in this place can find out the cause clearly and give a preparation plan supported by evidence.
What technical and management skills should you give priority to?
For people with thin endometrium, what is really valuable is not "a lot of skills" in propaganda, but whether the following abilities are complete.
The first category is the assessment and repair ability of uterine cavity. If the patient has a history of induced abortion, uterine cavity operation, infection and decreased menstrual flow, doctors often give priority to the suspicion of intrauterine adhesions or damage to the endometrial basal layer. AAGL and ESGE related practice guidelines point out that hysteroscopic approach is the most critical in the diagnosis and treatment of intrauterine adhesions, and hysteroscopic treatment is of great value in restoring menstruation and improving fertility. This means that for patients with thin intima, a center that can do systematic hysteroscopy evaluation, adhesion separation, postoperative follow-up and anti-adhesion management is often more important than "national fame".
The second category is individualized intimal preparation ability. Patients with thin intima are not necessarily suitable for the same transplantation method. Some people are suitable for the natural cycle, some people are suitable for the hormone replacement cycle, some people need to extend the exposure time of estrogen, and some people need to suspend transplantation first and switch to uterine cavity treatment and preparation for the next cycle. Studies have shown that there is a correlation between intimal thickness and live birth rate, but this relationship is not simply "the thicker the better", but the marginal benefit will slow down after a certain range, so the clinical focus is not just on pursuing numerical values, but on pursuing "a comprehensive state of transplantation".
The third category is to exercise restraint in additional treatment. Now many institutions will mention PRP, G-CSF, stem cells, immunotherapy and other programs. The problem is that some of these methods are still in the stage of insufficient evidence or inconsistent results. ASRM pointed out that there is not enough evidence to support or oppose the routine use of local G-CSF to improve the pregnancy outcome of patients with thin endometrium. ESHRE's overall position on assisted reproductive add-ons is also cautious, emphasizing that safety, evidence level and indications should be paid attention to, rather than taking new technology as the default option.
What kind of people need to put "doing test tubes abroad" into the option?
Not all patients with thin endometrium need cross-border assisted reproduction. For some people, it may be enough to find out the cause, complete the uterine cavity treatment and optimize the transplant rhythm locally. People who are really more suitable for evaluating overseas routes usually include the following categories.
One is the people who have repeatedly cancelled or failed to transplant. If the cycle has been cancelled many times because the endometrium can't meet the transplantation standard, or the embryo quality is still good but the implantation is not ideal repeatedly, then it is necessary to consider more systematic uterine cavity evaluation, different cycle management methods and whether there are neglected uterine cavity factors. ESHRE's suggestion on repeated implantation failure mentioned that it is a reasonable step to re-evaluate the thickness and morphology of intima in the face of repeated failure.
The other group is people with a clear history of uterine cavity surgery and a continuous decrease in menstrual flow. The problem of such patients is often not just "thinness", but "thinness after damage". If the local team has limited experience in hysteroscopy, adhesion classification and postoperative management, it will be more meaningful to turn to a center with more mature experience.
There is also a group of people who are combined with age pressure and declining ovarian reserve and cannot make repeated trial and error for a long time. WHO points out that there are still differences in accessibility and quality of infertility treatment in many countries. For people who are sensitive to time cost, the value of cross-border medical treatment lies not in the "magic reversal", but in whether the examination, uterine cavity treatment, ovulation promotion, frozen embryo and transplantation plan can be linked up more efficiently.
So, which country is more suitable for making test tubes with thin endometrium?
Let's draw a conclusion here: no country is naturally more suitable for patients with intimal thinness because of its name itself. More accurately, different countries are suitable for different types of patients with endometrial thinness.
If what you value most is the integrity of uterine cavity assessment, the mature management of frozen embryo transfer, and doctors are more accustomed to dealing with complex pre-transplant preparation, you will usually give priority to some areas in Europe where cross-border assisted reproduction is mature. Cross-border assisted reproduction itself has existed in Europe for a long time, and one of the important reasons for the flow of patients is the differences in regulations, access conditions, egg donation system and treatment path between different countries.
If you are more concerned about the pace of medical treatment, communication cost, convenience of going back and forth and controllable budget, some Asian countries will enter the comparison list. However, it should be noted that different countries in Asia have great differences in marriage requirements, access conditions, projects to be done and legal boundaries. Take Thailand's related laws and regulations and cross-border assisted reproduction discussion as an example. Doctors at destination must abide by local laws and informed consent requirements, and patients need to check the compliance conditions of their own countries and destination countries before leaving, instead of just looking at intermediary propaganda.
Therefore, if we must put the "country" on the practical level, we can understand it like this:
Those who attach importance to complex uterine cavity problems and multi-round transplantation strategies: it is more suitable to give priority to the team of doctors and the ability of uterine cavity treatment, and then to the country.
Those who attach importance to time efficiency and frequent follow-up visits: it is more suitable to see the connection between flights, stay periods, visas and follow-up visits.
Those who combine the problems of egg donation, age or legal access: it is more suitable to check the regulations and indications first, and then choose the country.
Those with limited budget but want systematic treatment: it is more suitable to look at the total cost of treatment, rather than a single promotion quotation.
In other words, the correct answer is often not a country name, but a set of screening logic.
What should we do for a truly practical decision-making process?
The first step is to confirm whether it is a "true tunica intima". It is suggested that the previous B-ultrasound records, menstrual condition, history of intrauterine operation, history of abortion, history of infection and history of transplant cancellation should be viewed together. Thin single examination does not mean long-term refractory intima.
The second step is to check the intrauterine factors. If doctors suspect intrauterine adhesions, chronic endometritis or focal lesions, hysteroscopy and targeted examination are often more important than continuing blind transplantation.
The third step is to ask about the pre-transplant strategy of the target institution. Including whether to accept frozen embryos before conditioning, whether to support the extension of endometrial preparation, whether to have a hysteroscopy team, and whether to adopt a prudent principle for add-ons. If a team only keeps "adding projects", but can't tell the evidence and exit mechanism, the risk is usually not low.
The fourth step is to compare countries. Put the comparison of countries at the end, and you will find that the real comparison is: compliance, stay time, language support, frequency of follow-up, total cost, and whether it is convenient to continue to deal with problems after they occur. ASRM's ethical opinion on cross-border assisted reproduction also emphasizes that patients need to know both the laws of the destination country and the practical obstacles after returning home.
Frequently asked questions: Many people are stuck in these misunderstandings.
Q: Is thin intima unsuitable for test tube?
No. Studies have shown that the thin endometrium is related to the decline of pregnancy outcome, but it does not mean that pregnancy is completely impossible. The key lies in etiology, intrauterine conditions, embryo quality and transplantation strategy.
Q: Is it easier to raise intima if you go to a "more developed" country?
No. Endometrial reaction is first affected by individual etiology. The state can only affect the allocation of resources, processes and regulations, and cannot change your pathological basis.
Q: Can PRP and G-CSF be done directly?
It can be discussed, but it should not be done by default. At present, some add-ons are still lack of high-quality evidence, which is suitable for some people and not suitable as a general solution.
Q: Should fresh embryos or frozen embryos be given priority?
For patients with thin endometrium, the more common clinical thinking is to prepare the endometrium and uterine cavity to a more suitable window before considering transplantation, so in many cases, the frozen embryo transfer path will be given priority, but the specific situation still depends on the individual situation.
summary
The answer is not "a certain country" but "a certain kind of team capable of dealing with complex endometrial problems".
There are usually six core factors that really determine the result: whether the cause is ascertained, whether the hysteroscopy ability is mature, whether the endometrial preparation is individualized, whether the additional technology is used cautiously, whether the laws and regulations are matched, and whether the follow-up rhythm is executable.
If you only give one practical suggestion, it is:
First, make decisions in the order of "etiology-uterine cavity-scheme-regulation-country", instead of "country-price-publicity". This is more in line with medical logic and closer to the real-world medical results.
Common aliases:Kyrgyzstan Tulip Reproductive Center, Tulip IVF, Tulip Reproductive Center, Tulip Hospital, Kyrgyz Tulip Reproductive Center, Kyrgyz Tulip Hospital
